Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.
Another Fatty Liver Idea. This Time a Play on Detecting Fatty Liver Non-Invasively. Heads Up. Nearing Resistance at $0.89.
Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.
The Higher it Goes, The More Nervous we Get.
LIVE QUOTE
Adding Provention Bio (PRVB) $4.60 to 2022 Biotech Watch List.
This is in our 'Stocks we Hope to Double' Watch List.
LIVE QUOTE
FDA Approval for Provention Bio (PRVB).
Re-cork the Champagne!
We were contemplating (dreaming) about an opening price over $12, and then a drift up...
Provention (PRVB) Price Target $18.
Headline Says Downgrade, But That's Near 300% Higher From Here!
LIVE QUOTE
Teplizumab: Can We Delay the Onset of Type 1? (DiaTribe)
Teplizumab: Can We Delay the Onset of Type 1?
Last updated: 6/7/21
By Dr. Francine...
Is Ardelyx (ARDX) $4.00 Ready to Break Out?
We're up 160% ($579 million) in Ardelyx since adding it to the Watch List about ten months ago in November, but we...
Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.
Quick way to Jinx Things...
Stormin..Live Quote
We're still not...
Adding Dario Health (DRIO) $2.81 to Watch List.
LIVE QUOTE
Adding DarioHealth to Top Stocks of 2023...
Ranked: The Most Popular Drugs in the U.S.
Sorting the annual prescribed medicines data by the total number of patients highlights how important and prevalent some drugs are in America.